JENBURKT PHARMACEUTICALS
Back to Balance Sheet
|
JENBURKT PHARMACEUTICALS Last 5 Year Deferred Tax Assets / Liabilities History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Deferred Tax Assets / Liabilities | ₹-0.38 Cr | ₹-0.01 Cr | ₹0.29 Cr | ₹0.49 Cr | ₹0.08 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of JENBURKT PHARMACEUTICALS ?
| Year | Deferred Tax Assets / Liabilities |
|---|---|
| Mar2025 | ₹-0.38 Cr |
| Mar2024 | ₹-0.01 Cr |
| Mar2023 | ₹0.29 Cr |
| Mar2022 | ₹0.49 Cr |
| Mar2021 | ₹0.08 Cr |
How is Deferred Tax Assets / Liabilities of JENBURKT PHARMACEUTICALS Trending?
| Years | Deferred Tax Assets / Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹-0.38 Cr | Negative | |
| Mar2024 | ₹-0.01 Cr | Negative | |
| Mar2023 | ₹0.29 Cr | -39.59 | |
| Mar2022 | ₹0.49 Cr | 484.34 | |
| Mar2021 | ₹0.08 Cr | - | |
Compare Deferred Tax Assets / Liabilities of peers of JENBURKT PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| JENBURKT PHARMACEUTICALS | ₹466.6 Cr | -1.5% | -5.3% | -2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹408,439.0 Cr | 6.8% | -1.5% | -2.4% | Stock Analytics | |
| DIVIS LABORATORIES | ₹162,903.0 Cr | 0% | -4.8% | 8.3% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹134,466.0 Cr | 1.7% | 4.1% | 20.5% | Stock Analytics | |
| CIPLA | ₹107,653.0 Cr | 0.1% | -12.8% | -9.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,924.0 Cr | 1.8% | -0.7% | 3.4% | Stock Analytics | |
JENBURKT PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| JENBURKT PHARMACEUTICALS | -1.5% |
-5.3% |
-2% |
| SENSEX | 1.5% |
-2.3% |
9.5% |
You may also like the below Video Courses